|
Repurposing Bumetanide to Address Cognitive Deficits in Schizophrenia
NU 2019-067
INVENTORS
Herbert Y. Meltzer
SHORT DESCRIPTION
Repurposing bumetaide to treat cognitive deficits in schizophrenia syndrome.
ABSTRACT
Cognitive deficits associated with schizophrenia syndrome are the components that contribute most to a low quality of life. While current pharmacological treatments have beneficial effects on treating...
Published: 5/13/2026
|
Updated: 5/30/2023
|
Inventor(s):
Keywords(s): Neurologic disease, Neurology, PSD - Psychotic spectrum disorder, Repurposed Drugs, Schizophrenia, Small molecule, Therapeutics
Category(s): Life Sciences > Therapeutics
|